Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B

References

• Amekyeh H, Billa N, Yuen K, Chin LS. 2015. A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. AAPS PharmSciTech. 16:871–877.
   PubMed Web of Science ®Google Scholar
• Amekyeh H, Billa N, Roberts C. 2017. Correlating gastric emptying of amphotericin B and paracetamol solid lipid nanoparticles with changes in particle surface chemistry. Int J Pharma. 517:42–49.
   PubMed Web of Science ®Google Scholar
• Bartlett K, Yau E, Hartsel SC, Hamer A, Tsai G, Bizzotto D, Wasan KM. 2004. Effect of heat-treated amphotericin B on renal and fungal cytotoxicity. Antimicrob Agents Chemother. 48:333–336.
   PubMed Web of Science ®Google Scholar
• Barwicz J, Christian S, Gruda I. 1992. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother. 36:2310–2315.
   PubMed Web of Science ®Google Scholar
• Benincasa M, Pacor S, Wu W, Prato M, Bianco A, Gennaro R. 2011. Antifungal activity of amphotericin B conjugated to carbon nanotubes. ACS Nano. 5:199–208.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S. 2016. DLS and zeta potential – what they are and what they are not?. J Controlled Release. 235:337–351.
   PubMed Web of Science ®Google Scholar
• Bianco MA, Gallarate M, Trotta M, Battaglia L. 2010. Amphotericin B loaded SLN prepared with the coacervation technique. J Drug Deliv Sci Technol. 20:187–191.
   Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Ferrari F, Rossi S, Larghi V, Zambito Y, Caramella C. 2010. Comparison of different in vitro and ex vivo methods to evaluate mucoadhesion of glycol-palmitoyl chitosan micelles. J Drug Deliv Sci Technol. 20:419–424.
   Web of Science ®Google Scholar
• Butani D, Yewale C, Misra A. 2016. Topical amphotericin B solid lipid nanoparticles: design and development. Collo Surf B: Biointer. 139:17–24.
   PubMed Web of Science ®Google Scholar
• Caldeira LR, Fernandes FR, Costa DF, Frezard F, Afonso LCC, Ferreira LAM. 2015. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis. Eur J Pharma Sci. 70:125–131.
   PubMed Web of Science ®Google Scholar
• Chaudhari MB, Desai PP, Patel PA. 2016. Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module. Drug Deliv Transl Res. 6:354–364.
   PubMed Web of Science ®Google Scholar
• Espada R, Valdespena S, Dea MA, Molero G, Ballesteros MP, Bolas F, Torrado JJ. 2008. Effect of aggregation state on the toxicity of different amphotericin B preparations. Int J Pharma. 361:64–69.
   PubMed Web of Science ®Google Scholar
• Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. 1988. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 29:1035–1041.
   PubMed Web of Science ®Google Scholar
• Gagoś M, Hereć M, Arczewska M, Czernel G, Dalla Serra M, Gruszecki WI. 2008. Anomalously high aggregation level of the polyene antibiotic amphotericin B in acidic medium: implications for the biological action. Biophys Chem. 136:44–49.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. 1998. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharma. 166:75–88.
   Web of Science ®Google Scholar
• Hu FQ, Jiang S, Du Y, Yuan H, Ye Y, Zeng S. 2005. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surfaces B: Biointerf. 45:167–173.
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh VK, Singh OP, Shafaat K, Kumar S, Ahmad FJ. 2016. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of amphotericin B. Drug Delivery. 23:3101–3110.
   PubMed Web of Science ®Google Scholar
• Italia JL, Yahya MM, Singh D, Kumar MNVR. 2009. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone®. Pharm Res. 26:1324–1331.
   PubMed Web of Science ®Google Scholar
• Jain S, Valvi PU, Swarnakar NK, Thanki K. 2012. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol Pharmaceutics. 9:2542–2553.
   PubMed Web of Science ®Google Scholar
• Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, Chourasia MK. 2014. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles. Appl Biochem Biotechnol. 174:1309–1330.
   PubMed Web of Science ®Google Scholar
• Jung SH, Lim DW, Jung SH, Lee JE, Jeong K, Seong H, Shin BC. 2009. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci. 37:313–320.
   PubMed Web of Science ®Google Scholar
• Kayser O, Olbrich C, Yardley V, Kiderlen AF, Croft SL. 2003. Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm. 254:73–75.
   PubMed Web of Science ®Google Scholar
• Kumar V, Adamson DH, Prud’homme RK. 2010. Fluorescent polymeric nanoparticles: aggregation and phase behavior of pyrene and amphotericin B molecules in nanoparticle cores. Small. 6:2907–2914.
   PubMed Web of Science ®Google Scholar
• Lance MR, Washington C, Davis SS. 1995. Structure and toxicity of amphotericin B/triglyceride emulsion formulations. J Antimicrob Chemother. 36:119–128.
   PubMed Web of Science ®Google Scholar
• Legrand P, Romero EA, Cohen BE, Bolard J. 1992. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob Agent Chemother. 36:2518–2522.
   PubMed Web of Science ®Google Scholar
• Li J, Liu D, Tan G, Zhao Z, Yang X, Pan W. 2016. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Carbohydr Polym. 146:435–444.
   PubMed Web of Science ®Google Scholar
• Liu M, Chen M, Yang Z. 2017. Design of amphotericin B oral formulation for antifungal therapy. Drug Deliv. 24:1–9.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, Wang Q. 2015. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydrate Polym. 122:221–229.
   PubMed Web of Science ®Google Scholar
• Lv W, Zhao S, Yu H, Li N, Garamus VM, Chen Y, Yin P, Zhang R, Gong Y, Zou A. 2016. Brucea javanica oil-loaded nanostructure lipid carriers (BJO NLCs): preparation, characterization and in vitro evaluation. Colloids Surf A: Physicochem Eng Aspects. 504:312–319.
   Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. 2008. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 34:1394–1405.
   PubMed Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. 2008. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotechnol Biol, Med. 4:252–261.
   PubMed Web of Science ®Google Scholar
• Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K. 2014. Lipid based nanocarrier system for the potential oral delivery of decitabine: Formulation design, characterization, ex vivo, and in vivo assessment. Int J Pharm. 477:601–612.
   PubMed Web of Science ®Google Scholar
• Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ. 1986. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterol. 90:958–962.
   PubMed Web of Science ®Google Scholar
• Radwan MA, AlQuadeib BT, Siller L, Wright MC, Horrocks B. 2017. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. Drug Deliv. 24:40–50.
   PubMed Web of Science ®Google Scholar
• Rençber S, Karavana SY, Yilmaz FF, Erac B, Nenni M, Ozbal S, Pekcetin C, Gurer-Orhan H, Hosgor-Limoncu M, Guneri P, Ertan G. 2016. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomed. 11:2641–2653.
   PubMed Web of Science ®Google Scholar
• Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Duran N. 2012. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces. 93:36–40.
   PubMed Web of Science ®Google Scholar
• Sandri G, Motta S, Bonferoni MC, Brocca P, Rossi S, Ferrari F, Rondelli V, Cantu L, Caramella C, Favero ED. 2017. Chitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesion. Eur J Pharma Biopharm. 110:13–18.
   PubMed Web of Science ®Google Scholar
• Santangelo R, Paderu P, Delmas G, Chen Z, Mannino R, Zarif L, Perlin DS. 2000. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother. 44:2356–2360.
   PubMed Web of Science ®Google Scholar
• Santos CM, Oliveira RB, Arantes VT, Caldeira LR, Oliveira MC, Egito EST, Ferreira LAM. 2012. Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: Development, characterization, and in vitro skin permeation studies. J Biomed Nanotechnol. 8:322–329.
   PubMed Web of Science ®Google Scholar
• Silva AE, Barratt G, Cheron M, Egito EST. 2013. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int J Pharm. 454:641–648.
   PubMed Web of Science ®Google Scholar
• Tan SW, Billa N, Roberts CR, Burley JC. 2010. Surfactant effects on the physical characteristics of amphotericin B-containing nanostructured lipid carriers. Colloids Surf A. Physicochem Eng Aspects. 372:73–79.
   Web of Science ®Google Scholar
• Tan SW, Billa N. 2014. Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles. AAPS PharmSciTech. 15:287–295.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. 2007. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 - Development, physicochemical characterization and in vitro release studies. Eur J Pharma Biopharma. 67:141–148.
   PubMed Web of Science ®Google Scholar
• Van de Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P, Kayaert P, Van den Mooter G, Weyenberg W, Cos P, Maes L, Ludwig A. 2012. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release. 161:795–803.
   PubMed Web of Science ®Google Scholar
• Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, Gagnon J, Gates B, Leon CG, Wasan KM. 2009. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharma. 372:76–84.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tan Y, Chen M, Dian L, Shan Z, Peng X, Wu C. 2012. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech. 13:1483–1491.
   PubMed Web of Science ®Google Scholar
• Ying XY, Cui D, Yu L, Du YZ. 2011. Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin. Carbohydrate Polym. 84:1357–1364.
   Web of Science ®Google Scholar
• Yoon G, Park JW, Yoon I. 2013. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharma Invest. 43:353–362.
   Google Scholar
• Yostawonkul J, Surassmo S, Iempridee T, Pimtong W, Suktham K, Sajomsang W, Gonil P, Ruktanonchai UR. 2017. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier. Colloids Surf B: Biointerf. 149:301–311.
   PubMed Web of Science ®Google Scholar